{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:03:24Z","timestamp":1790168604136,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-79686-4","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T02:14:00Z","timestamp":1731636840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of metabolites associated with ADIPOQ genotypes in individuals with type 2 diabetes mellitus"],"prefix":"10.1038","volume":"14","author":[{"given":"Tain\u00e1 Gomes","family":"Diniz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Severo","family":"de Assis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Rafael Virginio","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila Sabino","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre S\u00e9rgio","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella Wanderley","family":"de Queiroga Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Gon\u00e7alves Monteiro","family":"Viturino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri Mangueira","family":"do Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evandro Ferreira","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josean Fechine","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mussara Gomes Cavalcanti Alves","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla Patricia Novaes","family":"dos Santos Fechine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anauara Lima","family":"e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5291-5454","authenticated-orcid":false,"given":"Darlene Camati","family":"Persuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"79686_CR1","volume-title":"Diagnosis and Management of Type 2 Diabetes; 2020","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Diagnosis and Management of Type 2 Diabetes; 2020 (World Health Organization, 2020)."},{"issue":"9","key":"79686_CR2","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S2213-8587(22)00186-3","volume":"10","author":"E Cousin","year":"2022","unstructured":"Cousin, E. et al. Burden of diabetes and hyperglycaemia in adults in the Americas, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Diabetes Endocrinol. 10(9), 655\u2013667 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"7","key":"79686_CR3","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.2337\/dci20-0022","volume":"43","author":"WK Chung","year":"2020","unstructured":"Chung, W. K. et al. Precision medicine in diabetes: a consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 43(7), 1617\u20131635 (2020).","journal-title":"Diabetes Care"},{"issue":"11","key":"79686_CR4","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s00125-022-05731-4","volume":"65","author":"C Schiborn","year":"2022","unstructured":"Schiborn, C. & Schulze, M. B. Precision prognostics for the development of complications in diabetes. Diabetologia 65(11), 1867\u20131882 (2022).","journal-title":"Diabetologia"},{"issue":"7","key":"79686_CR5","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.3390\/pharmaceutics14071430","volume":"14","author":"MA Aljafary","year":"2022","unstructured":"Aljafary, M. A. & Al-Suhaimi, E. A. Adiponectin system (rescue hormone): the missing link between metabolic and cardiovascular diseases. Pharmaceutics 14(7), 1430 (2022).","journal-title":"Pharmaceutics"},{"issue":"2","key":"79686_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1681\/ASN.2012040414","volume":"24","author":"JM Rutkowski","year":"2013","unstructured":"Rutkowski, J. M. et al. Adiponectin promotes functional recovery after podocyte ablation. Journal of the American Society of Nephrology 24(2), 268\u2013282 (2013).","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"79686_CR7","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/90992","volume":"7","author":"AH Berg","year":"2001","unstructured":"Berg, A. H., Combs, T. P., Du, X., Brownlee, M. & Scherer, P. E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature medicine 7(8), 947\u2013953 (2001).","journal-title":"Nature medicine"},{"key":"79686_CR8","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.03851","volume":"3","author":"R Ye","year":"2014","unstructured":"Ye, R. et al. Adiponectin is essential for lipid homeostasis and survival under insulin deficiency and promotes \u03b2-cell regeneration. Elife 3, e03851 (2014).","journal-title":"Elife"},{"issue":"22","key":"79686_CR9","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1161\/01.CIR.0000042707.50032.19","volume":"106","author":"Y Okamoto","year":"2002","unstructured":"Okamoto, Y. et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106(22), 2767\u20132770 (2002).","journal-title":"Circulation"},{"issue":"2","key":"79686_CR10","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.bbrc.2005.03.210","volume":"331","author":"K Oshima","year":"2005","unstructured":"Oshima, K. et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochemical and biophysical research communications 331(2), 520\u2013526 (2005).","journal-title":"Biochemical and biophysical research communications"},{"issue":"3","key":"79686_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s11883-007-0025-4","volume":"9","author":"Y Takemura","year":"2007","unstructured":"Takemura, Y., Walsh, K. & Ouchi, N. Adiponectin and cardiovascular inflammatory responses. Current atherosclerosis reports 9(3), 238\u2013243 (2007).","journal-title":"Current atherosclerosis reports"},{"issue":"13","key":"79686_CR12","doi-asserted-by":"publisher","first-page":"12152","DOI":"10.1074\/jbc.M311113200","volume":"279","author":"UB Pajvani","year":"2004","unstructured":"Pajvani, U. B. et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. Journal of Biological Chemistry 279(13), 12152\u201312162 (2004).","journal-title":"Journal of Biological Chemistry"},{"issue":"10","key":"79686_CR13","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.2337\/dc11-0531","volume":"34","author":"AJ Hanley","year":"2011","unstructured":"Hanley, A. J. et al. Adiponectin and the incidence of type 2 diabetes in Hispanics and African Americans: the IRAS Family Study. Diabetes care 34(10), 2231\u20132236 (2011).","journal-title":"Diabetes care"},{"key":"79686_CR14","doi-asserted-by":"crossref","unstructured":"Alfaqih, M. A., Al-Hawamdeh, A., Amarin, Z. O., Khader, Y. S., Mhedat, K., & Allouh, M. Z. (2022). Single nucleotide polymorphism in the ADIPOQ gene modifies adiponectin levels and glycemic control in type two diabetes mellitus patients. BioMed Research International, 2022.","DOI":"10.1530\/endoabs.81.P61"},{"issue":"4","key":"79686_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jdiacomp.2008.05.004","volume":"23","author":"D Zhang","year":"2009","unstructured":"Zhang, D., Ma, J., Brismar, K., Efendic, S. & Gu, H. F. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study. Journal of Diabetes and its Complications 23(4), 265\u2013272 (2009).","journal-title":"Journal of Diabetes and its Complications"},{"key":"79686_CR16","doi-asserted-by":"publisher","first-page":"4395266","DOI":"10.1155\/2022\/4395266","volume":"2022","author":"G Wang","year":"2022","unstructured":"Wang, G., Wang, Y. & Luo, Z. Effect of Adiponectin Variant on Lipid Profile and Plasma Adiponectin Levels: A Multicenter Systematic Review and Meta-Analysis. Cardiovascular therapeutics 2022, 4395266. https:\/\/doi.org\/10.1155\/2022\/4395266 (2022).","journal-title":"Cardiovascular therapeutics"},{"key":"79686_CR17","doi-asserted-by":"crossref","unstructured":"Sun, P., Liu, L., Chen, J., Chen, Y., Shi, L., Imam, M. U., et al. (2017). The polymorphism of rs266729 in adiponectin gene and type 2 diabetes mellitus: a meta-analysis. Medicine, 96(47).","DOI":"10.1097\/MD.0000000000008745"},{"key":"79686_CR18","doi-asserted-by":"crossref","unstructured":"De Luis, D. A., Izaola, O., Primo, D., & Aller, R. (2020). Relation of a variant in adiponectin gene (rs266729) with metabolic syndrome and diabetes mellitus type 2 in adult obese subjects.\u00a0European Review for Medical & Pharmacological Sciences,\u00a024(20).","DOI":"10.1159\/000503863"},{"issue":"8","key":"79686_CR19","doi-asserted-by":"publisher","first-page":"13012","DOI":"10.1002\/jcb.28572","volume":"120","author":"L Wu","year":"2019","unstructured":"Wu, L. & Wang, C. C. Genetic variants in promoter regions associated with type 2 diabetes mellitus: A large-scale meta-analysis and subgroup analysis. Journal of Cellular Biochemistry 120(8), 13012\u201313025 (2019).","journal-title":"Journal of Cellular Biochemistry"},{"key":"79686_CR20","doi-asserted-by":"crossref","unstructured":"Truong, S., Tran, N. Q., Ma, P. T., Hoang, C. K., Le, B. H., Dinh, T., et al. (2022). Association of ADIPOQ single-nucleotide polymorphisms with the two clinical phenotypes type 2 diabetes mellitus and metabolic syndrome in a Kinh Vietnamese population.\u00a0Diabetes, metabolic syndrome and obesity: targets and therapy, 307\u2013319.","DOI":"10.2147\/DMSO.S347830"},{"key":"79686_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2350-9-45","volume":"9","author":"S Cauchi","year":"2008","unstructured":"Cauchi, S. et al. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC medical genetics 9, 1\u20139 (2008).","journal-title":"BMC medical genetics"},{"issue":"10","key":"79686_CR22","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3390\/biom9100537","volume":"9","author":"S Smetnev","year":"2019","unstructured":"Smetnev, S. et al. Associations of SNPs of the ADIPOQ gene with serum adiponectin levels, unstable angina, and coronary artery disease. Biomolecules 9(10), 537 (2019).","journal-title":"Biomolecules"},{"issue":"10","key":"79686_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241365","volume":"15","author":"JH Yun","year":"2020","unstructured":"Yun, J. H. et al. Metabolomics profiles associated with diabetic retinopathy in type 2 diabetes patients. PLoS One 15(10), e0241365 (2020).","journal-title":"PLoS One"},{"issue":"4","key":"79686_CR24","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1039\/C6MB00014B","volume":"12","author":"LA Filla","year":"2016","unstructured":"Filla, L. A. & Edwards, J. L. Metabolomics in diabetic complications. Molecular BioSystems 12(4), 1090\u20131105 (2016).","journal-title":"Molecular BioSystems"},{"issue":"10","key":"79686_CR25","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/eurheartj\/ehp090","volume":"30","author":"SL Prior","year":"2009","unstructured":"Prior, S. L. et al. Association between the adiponectin promoter rs266729 gene variant and oxidative stress in patients with diabetes mellitus. European Heart Journal 30(10), 1263\u20131269 (2009).","journal-title":"European Heart Journal"},{"key":"79686_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.clnesp.2024.03.013","volume":"61","author":"TG Diniz","year":"2024","unstructured":"Diniz, T. G. et al. Metabolomic analysis of retinopathy stages and amputation in type 2 diabetes. Clinical Nutrition ESPEN 61, 158\u2013167 (2024).","journal-title":"Clinical Nutrition ESPEN"},{"issue":"5","key":"79686_CR27","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/ATVBAHA.112.301089","volume":"33","author":"MM Joosten","year":"2013","unstructured":"Joosten, M. M. et al. Total adiponectin and risk of symptomatic lower extremity peripheral artery disease in men. Arteriosclerosis, thrombosis, and vascular biology 33(5), 1092\u20131097 (2013).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"issue":"9","key":"79686_CR28","doi-asserted-by":"publisher","first-page":"8128","DOI":"10.3390\/ijms24098128","volume":"24","author":"HH Chen","year":"2023","unstructured":"Chen, H. H. et al. Chronic Kidney Disease: Interaction of Adiponectin Gene Polymorphisms and Diabetes. International journal of molecular sciences 24(9), 8128 (2023).","journal-title":"International journal of molecular sciences"},{"issue":"2","key":"79686_CR29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3390\/nu13020541","volume":"13","author":"O Coltell","year":"2021","unstructured":"Coltell, O. et al. Circulating adiponectin and its association with metabolic traits and Type 2 Diabetes: Gene-diet interactions focusing on selected gene variants and at the genome-wide level in high-cardiovascular risk Mediterranean subjects. Nutrients 13(2), 541 (2021).","journal-title":"Nutrients"},{"issue":"1","key":"79686_CR30","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41598-017-18709-9","volume":"8","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Plasma adiponectin levels and type 2 diabetes risk: a nested case-control study in a Chinese population and an updated meta-analysis. Scientific reports 8(1), 406 (2018).","journal-title":"Scientific reports"},{"key":"79686_CR31","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10099","volume":"8","author":"PT Williams","year":"2020","unstructured":"Williams, P. T. Quantile-dependent expressivity of plasma adiponectin concentrations may explain its sex-specific heritability, gene-environment interactions, and genotype-specific response to postprandial lipemia. PeerJ 8, e10099 (2020).","journal-title":"PeerJ"},{"issue":"2","key":"79686_CR32","doi-asserted-by":"publisher","first-page":"e982","DOI":"10.1210\/clinem\/dgaa898","volume":"106","author":"A Lehn-Stefan","year":"2021","unstructured":"Lehn-Stefan, A. et al. Elevated circulating glutamate is associated with subclinical atherosclerosis independently of established risk markers: A cross-sectional study. The Journal of Clinical Endocrinology & Metabolism 106(2), e982\u2013e989 (2021).","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"79686_CR33","doi-asserted-by":"publisher","first-page":"6197","DOI":"10.1038\/s41598-021-85684-7","volume":"11","author":"E Porcu","year":"2021","unstructured":"Porcu, E. et al. Triangulating evidence from longitudinal and Mendelian randomization studies of metabolomic biomarkers for type 2 diabetes. Scientific Reports 11(1), 6197 (2021).","journal-title":"Scientific Reports"},{"key":"79686_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11306-018-1383-3","volume":"14","author":"SY Rhee","year":"2018","unstructured":"Rhee, S. Y. et al. Plasma glutamine and glutamic acid are potential biomarkers for predicting diabetic retinopathy. Metabolomics 14, 1\u201310 (2018).","journal-title":"Metabolomics"},{"issue":"4","key":"79686_CR35","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1093\/ajcn\/nqz169","volume":"110","author":"SL Navarro","year":"2019","unstructured":"Navarro, S. L. et al. Plasma metabolomics profiles suggest beneficial effects of a low\u2013glycemic load dietary pattern on inflammation and energy metabolism. The American journal of clinical nutrition 110(4), 984\u2013992 (2019).","journal-title":"The American journal of clinical nutrition"},{"key":"79686_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-021-01986-8","volume":"21","author":"M Hasani","year":"2021","unstructured":"Hasani, M. et al. Effect of glutamine supplementation on cardiometabolic risk factors and inflammatory markers: a systematic review and meta-analysis. BMC cardiovascular disorders 21, 1\u201321 (2021).","journal-title":"BMC cardiovascular disorders"},{"issue":"5","key":"79686_CR37","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2337\/dc15-2251","volume":"39","author":"M Guasch-Ferr\u00e9","year":"2016","unstructured":"Guasch-Ferr\u00e9, M. et al. Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis. Diabetes care 39(5), 833\u2013846 (2016).","journal-title":"Diabetes care"},{"issue":"1","key":"79686_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41387-022-00213-3","volume":"12","author":"F Vanweert","year":"2022","unstructured":"Vanweert, F., Schrauwen, P. & Phielix, E. Role of branched-chain amino acid metabolism in the pathogenesis of obesity and type 2 diabetes-related metabolic disturbances BCAA metabolism in type 2 diabetes. Nutrition & diabetes 12(1), 35 (2022).","journal-title":"Nutrition & diabetes"},{"key":"79686_CR39","doi-asserted-by":"crossref","unstructured":"Borges, M. C., Barros, A. J., Ferreira, D. L. S., Casas, J. P., Horta, B. L., Kivimaki, M., et al. (2017). Metabolic profiling of adiponectin levels in adults: Mendelian randomization analysis.\u00a0Circulation: Cardiovascular Genetics,\u00a010(6), e001837.","DOI":"10.1161\/CIRCGENETICS.117.001837"},{"issue":"4","key":"79686_CR40","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1210\/clinem\/dgz240","volume":"105","author":"Y Sun","year":"2020","unstructured":"Sun, Y., Gao, H. Y., Fan, Z. Y., He, Y. & Yan, Y. X. Metabolomics signatures in type 2 diabetes: a systematic review and integrative analysis. The Journal of Clinical Endocrinology & Metabolism 105(4), 1000\u20131008 (2020).","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"4","key":"79686_CR41","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ajcn\/nqaa016","volume":"111","author":"M Guasch-Ferr\u00e9","year":"2020","unstructured":"Guasch-Ferr\u00e9, M. et al. Glycolysis\/gluconeogenesis-and tricarboxylic acid cycle\u2013related metabolites, Mediterranean diet, and type 2 diabetes. The American journal of clinical nutrition 111(4), 835\u2013844 (2020).","journal-title":"The American journal of clinical nutrition"},{"key":"79686_CR42","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00726-020-02891-8","volume":"52","author":"W Lin","year":"2020","unstructured":"Lin, W. et al. Metabolomics and correlation network analyses of core biomarkers in type 2 diabetes. Amino acids 52, 1307\u20131317 (2020).","journal-title":"Amino acids"},{"issue":"3","key":"79686_CR43","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1210\/jc.2015-2640","volume":"101","author":"T Dutta","year":"2016","unstructured":"Dutta, T. et al. Impact of long-term poor and good glycemic control on metabolomics alterations in type 1 diabetic people. The Journal of Clinical Endocrinology & Metabolism 101(3), 1023\u20131033 (2016).","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"7","key":"79686_CR44","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/glycob\/9.7.679","volume":"9","author":"DJ Moloney","year":"1999","unstructured":"Moloney, D. J. & Haltiwanger, R. S. The O-linked fucose glycosylation pathway: identification and characterization of a uridine diphosphoglucose: fucose-\u03b21, 3-glucosyltransferase activity from Chinese hamster ovary cells. Glycobiology 9(7), 679\u2013687 (1999).","journal-title":"Glycobiology"},{"key":"79686_CR45","doi-asserted-by":"crossref","unstructured":"Al-Aama, J. Y., Al Mahdi, H. B., Salama, M. A., Bakur, K. H., Alhozali, A., Mosli, H. H., et al. (2019). Detection of secondary metabolites as biomarkers for the early diagnosis and prevention of type 2 diabetes. Diabetes, metabolic syndrome and obesity: targets and therapy, 2675\u20132684.","DOI":"10.2147\/DMSO.S215528"},{"key":"79686_CR46","first-page":"230","volume":"28","author":"KO Chu","year":"2022","unstructured":"Chu, K. O. et al. Untargeted metabolomic analysis of aqueous humor in diabetic macular edema. Molecular Vision 28, 230 (2022).","journal-title":"Molecular Vision"},{"issue":"3","key":"79686_CR47","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1210\/me.2009-0152","volume":"24","author":"LO Li","year":"2010","unstructured":"Li, L. O. et al. Early hepatic insulin resistance in mice: a metabolomics analysis. Molecular endocrinology 24(3), 657\u2013666 (2010).","journal-title":"Molecular endocrinology"},{"issue":"9","key":"79686_CR48","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1038\/s41436-019-0442-0","volume":"21","author":"LC Burrage","year":"2019","unstructured":"Burrage, L. C. et al. Untargeted metabolomic profiling reveals multiple pathway perturbations and new clinical biomarkers in urea cycle disorders. Genetics in Medicine 21(9), 1977\u20131986 (2019).","journal-title":"Genetics in Medicine"},{"issue":"1","key":"79686_CR49","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1161\/CIRCRESAHA.107.155028","volume":"102","author":"MJ Romero","year":"2008","unstructured":"Romero, M. J. et al. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circulation research 102(1), 95\u2013102 (2008).","journal-title":"Circulation research"},{"issue":"1","key":"79686_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-017-0974-6","volume":"15","author":"M Pietzner","year":"2017","unstructured":"Pietzner, M. et al. Comprehensive metabolic profiling of chronic low-grade inflammation among generally healthy individuals. BMC medicine 15(1), 1\u201312 (2017).","journal-title":"BMC medicine"},{"issue":"4","key":"79686_CR51","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1096\/fj.10-173377","volume":"25","author":"J Carracedo","year":"2011","unstructured":"Carracedo, J. et al. Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells. The FASEB Journal 25(4), 1314\u20131322 (2011).","journal-title":"The FASEB Journal"},{"key":"79686_CR52","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1007\/s00125-016-4069-2","volume":"59","author":"Y Lu","year":"2016","unstructured":"Lu, Y. et al. Metabolic signatures and risk of type 2 diabetes in a Chinese population: an untargeted metabolomics study using both LC-MS and GC-MS. Diabetologia 59, 2349\u20132359 (2016).","journal-title":"Diabetologia"},{"key":"79686_CR53","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fendo.2019.00050","volume":"10","author":"YF Cao","year":"2019","unstructured":"Cao, Y. F. et al. Plasma levels of amino acids related to urea cycle and risk of type 2 diabetes mellitus in Chinese adults. Frontiers in endocrinology 10, 50 (2019).","journal-title":"Frontiers in endocrinology"},{"issue":"2","key":"79686_CR54","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cmet.2019.11.019","volume":"31","author":"P Petrus","year":"2020","unstructured":"Petrus, P. et al. Glutamine links obesity to inflammation in human white adipose tissue. Cell metabolism 31(2), 375\u2013390 (2020).","journal-title":"Cell metabolism"},{"issue":"12","key":"79686_CR55","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.numecd.2019.08.015","volume":"29","author":"I Maltais-Payette","year":"2019","unstructured":"Maltais-Payette, I., Allam-Ndoul, B., P\u00e9russe, L., Vohl, M. C. & Tchernof, A. Circulating glutamate level as a potential biomarker for abdominal obesity and metabolic risk. Nutrition, Metabolism and Cardiovascular Diseases 29(12), 1353\u20131360 (2019).","journal-title":"Nutrition, Metabolism and Cardiovascular Diseases"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79686-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79686-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79686-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T07:05:33Z","timestamp":1731913533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79686-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["79686"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-79686-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"assertion":[{"value":"18 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declare that they have no conflicting interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicting interests"}}],"article-number":"28093"}}